Электронный архив

Просмотр по автору "Khasanova A.I."

Просмотр по автору "Khasanova A.I."

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 
    Kovalenko E.I.; Artamonova E.V.; Bolotina L.V.; Zhiliaeva L.A.; Ponomarenko D.M.; Karabina E.V.; Mukhametshina G.Z.; Khasanova A.I.; Ratner E.Y.; Safarova A.R.; Manikhas A.G.; Popova N.O.; Evstigneeva I.V.; Vladimirova L.Y.; Kramskaya L.V.; Karandeeva T.V.; Suslova I.R.; Romanchuk O.V.; Shikina V.E.; Povyshev A.Y.; Osipov M.A.; Cherniakova E.M.; Dergunov A.S.; Volkonskiy M.V.; Chernov I.S.; Shumskaya I.E.; Fael M.M.; Garifullina V.I.; Gudkova I.E. (2021)
    Introduction. The standard of 1st line treatment of HER2+ metastatic breast cancer (mBC) is double blockade with trastuzumab and pertuzumab + taxane, 2nd line – Trastuzumab-emtazine. There are no standards for further ...
  • The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia 
    Sokolova T.N.; Aleksakhina S.N.; Yanus G.A.; Sultanbaev A.V.; Menshikov K.V.; Lysenko A.N.; Zukov R.A.; Zyuzyukina A.V.; Murunova Y.N.; Rossokha E.I.; Bakharev S.Y.; Basova E.A.; Kasmynina T.A.; Shumskaya I.S.; Bakshun Y.I.; Musaeva K.S.; Khasanova A.I.; Dmitriev V.N.; Bolieva M.B.; Gadzaova C.H.; Petrenko O.L.; Maksimov D.A.; Vladimirov V.I.; Goldberg V.E.; Popova N.O.; Kibisheva M.V.; Khamgokov Z.M.; Vasilyev A.E.; Iyevleva A.G.; Imyanitov E.N. (2021)
    Relevance. PIK3CA belongs to the top three most frequently mutated genes in breast cancer (BC), especially in estrogen receptor (ER) positive, HER2 negative BC subtype. With an approval of selective PI3K-alpha inhibitor, ...
  • The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia 
    Sokolova T.N.; Aleksakhina S.N.; Yanus G.A.; Sultanbaev A.V.; Menshikov K.V.; Lysenko A.N.; Zukov R.A.; Zyuzyukina A.V.; Murunova Y.N.; Rossokha E.I.; Bakharev S.Y.; Basova E.A.; Kasmynina T.A.; Shumskaya I.S.; Bakshun Y.I.; Musaeva K.S.; Khasanova A.I.; Dmitriev V.N.; Bolieva M.B.; Gadzaova C.H.; Petrenko O.L.; Maksimov D.A.; Vladimirov V.I.; Goldberg V.E.; Popova N.O.; Kibisheva M.V.; Khamgokov Z.M.; Vasilyev A.E.; Iyevleva A.G.; Imyanitov E.N. (2021)
    Relevance. PIK3CA belongs to the top three most frequently mutated genes in breast cancer (BC), especially in estrogen recep-tor (ER) positive, HER2 negative BC subtype. With an approval of selective PI3K-alpha inhibitor, ...

Поиск в электронном архиве

Просмотр

Моя учетная запись